H. Ralph Snodgrass

2020

In 2020, H. Ralph Snodgrass earned a total compensation of $671.3K as President, Chief Scientific Officer at Vistagen Therapeutics, a 5% increase compared to previous year.

Compensation breakdown

Option Awards$254,405
Salary$416,850
Total$671,255

Snodgrass received $416.9K in salary, accounting for 62% of the total pay in 2020.

Snodgrass also received $254.4K in option awards.

Rankings

In 2020, H. Ralph Snodgrass' compensation ranked 10,116th out of 13,090 executives tracked by ExecPay. In other words, Snodgrass earned more than 22.7% of executives.

ClassificationRankingPercentile
All
10,116
out of 13,090
23rd
Division
Manufacturing
4,344
out of 5,621
23rd
Major group
Chemicals And Allied Products
1,792
out of 2,254
21st
Industry group
Drugs
1,568
out of 1,954
20th
Industry
Pharmaceutical Preparations
1,158
out of 1,459
21st
Source: SEC filing on July 27, 2020.

Snodgrass' colleagues

We found four more compensation records of executives who worked with H. Ralph Snodgrass at Vistagen Therapeutics in 2020.

2020

Shawn Singh

Vistagen Therapeutics

Chief Executive Officer

2020

Jerrold Dotson

Vistagen Therapeutics

Chief Financial Officer

2020

Mark Smith

Vistagen Therapeutics

Chief Medical Officer

2020

Mark McPartland

Vistagen Therapeutics

Vice President, Corporate Development

News

You may also like